Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.

Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.

The cannabinoid receptor 2 (CB2R) has been linked with the regulation of inflammation, and selective receptor activation has been proposed as a target for the treatment of a range of inflammatory diseases such as atherosclerosis and arthritis. In order to identify selective CB2R agonists with approp...

Bibliografiset tiedot
Päätekijät:	Gianella-Borradori, M, Christou, I, Bataille, C, Cross, R, Wynne, G, Greaves, D, Russell, A
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Elsevier 2015

Samankaltaisia teoksia

Virtual screening identifies a biologically active novel family of CB2R selective compounds (with improved physicochemical properties)
Tekijä: Christou, I, et al.
Julkaistu: (2011)

Pharmacophore-guided Virtual Screening to Identify New β3-adrenergic Receptor Agonists
Tekijä: Ujiantari, Navista Sri Octa, et al.
Julkaistu: (2022)

A biased agonist at immunometabolic receptor GPR84 causes distinct functional effects in macrophages
Tekijä: Lucy, D, et al.
Julkaistu: (2019)

Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons.
Tekijä: Anand, U, et al.
Julkaistu: (2008)

Kinetic insights into agonist-dependent signalling bias at the pro-inflammatory G-protein coupled receptor GPR84
Tekijä: Luscombe, VB, et al.
Julkaistu: (2023)

Novel family of CB2R agonists regulates inflammatory responses
Tekijä: Christou, I
Julkaistu: (2012)

Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment.
Tekijä: Kapellos, T, et al.
Julkaistu: (2019)

The identification & optimisation of endogenous signalling pathway modulators
Tekijä: Gianella-Borradori, ML
Julkaistu: (2013)

Cannabinoid receptor 2 modulates neutrophil recruitment in a murine model of endotoxemia.
Tekijä: Kapellos, T, et al.
Julkaistu: (2017)

Cannabinoid type 1 receptor antagonists for smoking cessation.
Tekijä: Cahill, K, et al.
Julkaistu: (2011)

Cannabinoid type 1 receptor antagonists for smoking cessation.
Tekijä: Cahill, K, et al.
Julkaistu: (2011)

Critical assessment of the role of cannabinoid receptor 2 in inflammation
Tekijä: Kapellos, T
Julkaistu: (2016)

Marijuana and the cannabinoids /
Tekijä: ElSohly, Mahmoud A.
Julkaistu: (2007)

Cannabinoid Receptor 1 Is Required for Neurodevelopment of Striosome-Dendron Bouquets
Tekijä: Crittenden, Jill R, et al.
Julkaistu: (2023)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
Tekijä: Cahill, K, et al.
Julkaistu: (2007)

Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex
Tekijä: Lee, J, et al.
Julkaistu: (2010)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
Tekijä: Cahill, K, et al.
Julkaistu: (2007)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
Tekijä: Cahill, K, et al.
Julkaistu: (2007)

Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex.
Tekijä: Lee, J, et al.
Julkaistu: (2010)

Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons.
Tekijä: Ahluwalia, J, et al.
Julkaistu: (2000)

Ligand binding induces agonistic-like conformational adaptations in helix 12 of progesterone receptor ligand binding domain
Tekijä: Zheng, Liangzhen, et al.
Julkaistu: (2019)

Neurotherapeutic potential of synthetic cannabinoid receptor agonist, WIN55,212-2 on Aluminium chloride and D-galactose- induced cognitive impairments in male Wistar rats
Tekijä: Onesimus, Mahdi
Julkaistu: (2021)

Virtual Target Construction for Discovery of Human Histamine H4 Receptor Ligands Employing A Structure-Based Virtual Screening Approach
Tekijä: Nugraha, Gerry, et al.
Julkaistu: (2022)

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
Tekijä: Clayton, N, et al.
Julkaistu: (2002)

Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism.
Tekijä: Lim, C, et al.
Julkaistu: (2013)

Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism
Tekijä: Lim, C, et al.
Julkaistu: (2013)

A genomic DNA reporter screen identifies squalene synthase inhibitors which act cooperatively with statins to upregulate the low-density lipoprotein receptor
Tekijä: Kerr, A, et al.
Julkaistu: (2017)

Structure and function of the CLEC-2 receptor and its ligands
Tekijä: Watson, A, et al.
Julkaistu: (2008)

Dysfunctional prefrontal cortical network activity and interactions following cannabinoid receptor activation.
Tekijä: Kucewicz, M, et al.
Julkaistu: (2011)

CB1 and CB2 cannabinoid receptors are implicated in inflammatory hypersensitivity to pain
Tekijä: Clayton, N, et al.
Julkaistu: (2001)

Mining free compound databases to identify candidates selected by virtual screening.
Tekijä: Vasudevan, SR, et al.
Julkaistu: (2009)

Identification of LasR ligands through a virtual screening approach
Tekijä: Skovstrup, Søren, et al.
Julkaistu: (2014)

Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade.
Tekijä: Purbhoo, M, et al.
Julkaistu: (1998)

Metabotropic glutamate receptor agonists for schizophrenia.
Tekijä: Harrison, P
Julkaistu: (2008)

Alternative splicing of a Drosophila GABA receptor subunit gene identifies determinants of agonist potency.
Tekijä: Hosie, A, et al.
Julkaistu: (2001)

Cannabinoid CB1 receptor binding and acetylcholinesterase inhibitory activity of Sceletium tortuosum L.
Tekijä: Lubbe, A., et al.
Julkaistu: (2010)

Cannabinoid CB1 receptor binding and acetylcholinesterase inhibitory activity of Sceletium tortuosum L.
Tekijä: Lubbe, Andrea, et al.
Julkaistu: (2010)

Cannabinoid receptor, CB1, expression follows neuronal differentiation in the early chick embryo.
Tekijä: Begbie, J, et al.
Julkaistu: (2004)

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist.
Tekijä: Pike, A, et al.
Julkaistu: (1999)

A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.
Tekijä: Goudet, C, et al.
Julkaistu: (2012)